Prévention de l'insuffisance rénale chronique chez l'adulte

Krzesinski, Jean-Marie; Dubois, Bernard; Rorive, Georges

Download

Article (Scientific journals)

Prévention de l'insuffisance rénale chronique chez l'adulte

Krzesinski, Jean-Marie; Dubois, Bernard; Rorive, Georges

2003 • In Revue Médicale de Liège, 58 (6), p. 369-377

Peer reviewed

Permalink
https://hdl.handle.net/2268/72112

PubMed
12945233

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

2003 Rev Med Liège 58 6 369-377.pdf

Publisher postprint (489.85 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Chronic renal failure; Prevention; risk factors; Renal disease; Dialysis; Transplantation

Abstract :

[en] Chronic renal failure is an unrecognised disease, with an insidious and rather silent development, for which the general practitioners are too often passive. This review would like to insist on the detection of people at risk or with early abnormalities, on the optimal guidelines to slowdown the evolution to more severe and irreversible stages, on the prevention of uremic and cardiovascular complications and on the preparation to end stage renal treatments.

Disciplines :

Urology & nephrology

Author, co-author :

Krzesinski, Jean-Marie ; Université de Liège - ULiège > Néphrologie

Dubois, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Rorive, Georges ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

Language :

French

Title :

Prévention de l'insuffisance rénale chronique chez l'adulte

Alternative titles :

[en] Prevention of chronic renal failure in the adult

Publication date :

June 2003

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Hopital de Baviere, Liège, Belgium

Volume :

Issue :

Pages :

369-377

Peer reviewed :

Peer reviewed

Available on ORBi :

since 15 September 2010

Statistics

Number of views

2326 (4 by ULiège)

Number of downloads

1895 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Hebert L, Wilmer W, Falkenhain M, et al. - Renoprotection: one or many therapies? Kidney Int, 2001, 59, 1211-1226.
Tulassoy T and Vasarhelyi B. - Birth weight and renal function. Curr Opin Nephrol Hypertens, 2002, 11, 347-352.
Staessen J, Nawrot T, Den Hond E, et al. - Renal functin, cytogenetic measurements, and sexual development in adolescents in relation to environmental polluants: a feasibility study of biomarkers. Lancet, 2001, 357, 1660-1669.
Ravnskov U, Lundström S and Norden A. - Hydrocarbon exposure and glomerulonephritis: evidence from patients'occupations. Lancet, 1983, 1214-1216.
Adler A, Stevens R, Manley S, et al. - Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int, 2003, 63, 225-232.
UK Prospective Diabetes Study Group. - Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 1998, 317, 703-713.
Parving H-H, Andersen A, Smidt U, Svendsen P. - Early aggresive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet, 1983, 1175-1179.
Lewis E, Hunsicker L, Bain R, Rohde R. - The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med, 1993, 329, 1456-1462.
Parving H-H, Lehnert H, Bröchner-Mortensen J, et al. - The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med, 2001, 345, 870-878.
Lewis E, Hunsicker L, Clarke W, et al. - Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med, 2001, 345, 851-860.
Brenner B, Cooper M, De Zeeuw D, et al. - Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 2001, 345, 861-869.
Praga M, Hernandez E, Herrero JC, et al. - Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int, 2000, 58, 2111-2118.
Agodoa LY, Appel L, Bakris GL, et al. - Effect of ramipril vs amiodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial, JAMA, 2001, 285, 2719.
Krzesinski J-M, Piront P. - Décompensation cardiaque, fonction rénale et anti-inflammatoires non stéroïdiens. Rev Med Liège, 2002, 57, 582-586.
Orth S, Ritz E. - The renal risks of smoking: an update. Curr Opin Nephrol Hypertens, 2002, 11, 483-488.
Parekh R and Klag M. - Alcohol: role in the development of hypertension and end-stage renal disease. Curr Opin Nephrol Hypertens, 2001, 10, 385-390.
Vanherweghem J-L, Depierreux M, Tielemans C, et al. - Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet, 1993, 341, 387-391.
de Jong P, Hillege H, Joan Pinto-Sietsma S, et al. - Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant, 2003, 18, 10-13.
Garg A, Kiberd B, Clark W, et al. - Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int, 2002, 61, 2165-2175.
Delanaye P, Chapelle J-P, Ferir A-M, et al. - La mesure du débit de filtration glomérulaire en clinique quotidienne. Rev Med Liège, 2003, 58, 95-100.
Elsevier M, Verpooten G, De Broe M. - Interpretation of creatinine clearance. Lancet, 1987, 457.
Levey A. - Non diabetic kidney disease. N Engl J Med, 2002, 347, 1505-1511.
Brenner B, Meyer T, Hostetter T. - Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med, 1982, 652-659.
Klahr S, Schreiner G, Ichikawa I. - The progression of renal disease. N Engl J Med, 1988, 318, 1657-1666.
Noronha I, Fujihara C, Zatz R. - The inflammatory component in progressive renal disease - are interventions possible? Nephrol Dial Transplant, 2002, 17, 363-368.
Rossert J, Wauters J-P. - Recommendations for the screening and management of patients with chronic kidney disease. Nephrol Dial Transplant, 2002, 17 (suppl 1), 19-28.
Locatelli R, Del Vecchio L, Pozzoni P - The importance of early detection of chronic kidney disease. Nephrol Dial Transplant, 2002, 17, (suppl 11), 2-7.
Klahr S, Levey A, Beck G, et al. - The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med, 1994, 330, 877-884.
Locatelli R, Del Vecchio L. - How long can dialysis be postponed by low protein diet and ACE inhibitors ? Nephrol Dial Transplant, 1999, 14, 1360-1364.
Taal M, Brenner B. - Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int, 2000, 57, 1803-1817.
Hannedouche T, Landais P, Esper N, et al. - Randomised controlled trial of enalapril and ßblockers in non-diabetic chronic renal failure. BMJ, 1994, 309, 833-837.
Bakris G, Williams B. - Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ? J Hypertension, 1995, 13 (suppl 2), S95-S101.
Wanner C, Quaschning T. - Dyslipidemia and renal disease: pathogenesis and clinical consequences. Curr Opin Nephrol Hypertens, 2001, 10, 195-201.
Fried L, Orchard T, Kasiske L (for the Lipids and Renal Disease Progression Meta-Analysis Study Group). - Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int, 2001, 59, 260-269.
Lin J-L, Lin-Tan D, Hsu K-H, Yu C-C. - Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med, 2003, 348, 277-286.
Pereira B. - Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int, 2000, 57, 351-365.
Jungers P. - Late referral: loss of chance for the patient, loss of money for society. Nephrol Dial Transplant, 2002, 17, 371-375.